177 related articles for article (PubMed ID: 17412566)
1. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance.
Pasqualotto AC; Denning DW
Int J Antimicrob Agents; 2007 Jul; 30(1):93-4. PubMed ID: 17412566
[No Abstract] [Full Text] [Related]
2. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
3. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
4. The impact of azole resistance on aspergillosis guidelines.
Georgiadou SP; Kontoyiannis DP
Ann N Y Acad Sci; 2012 Dec; 1272():15-22. PubMed ID: 23231710
[TBL] [Abstract][Full Text] [Related]
5. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air.
Vanhee LM; Perman D; Nelis HJ; Coenye T
J Microbiol Methods; 2010 May; 81(2):197-9. PubMed ID: 20193715
[TBL] [Abstract][Full Text] [Related]
6. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.
Dannaoui E; Persat F; Borel E; Piens MA; Picot S
Can J Microbiol; 2001 Aug; 47(8):706-10. PubMed ID: 11575496
[TBL] [Abstract][Full Text] [Related]
7. Hydrocortisone, prednisolone and dexamethasone act on Aspergillus fumigatus in vitro susceptibility to itraconazole.
Ramondenc I; Pinel C; Parat S; Ambroise-Thomas P; Grillot R
Microbios; 2001; 104(407):17-26. PubMed ID: 11229654
[TBL] [Abstract][Full Text] [Related]
8. Invasive aspergillosis with polyarthritis.
Mekan SF; Saeed O; Khan JA
Mycoses; 2004 Dec; 47(11-12):518-20. PubMed ID: 15601460
[TBL] [Abstract][Full Text] [Related]
9. Azole-resistant central nervous system aspergillosis.
van der Linden JW; Jansen RR; Bresters D; Visser CE; Geerlings SE; Kuijper EJ; Melchers WJ; Verweij PE
Clin Infect Dis; 2009 Apr; 48(8):1111-3. PubMed ID: 19272019
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
Patterson TF; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
[TBL] [Abstract][Full Text] [Related]
11. Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
Enserink M
Science; 2009 Nov; 326(5957):1173. PubMed ID: 19965440
[No Abstract] [Full Text] [Related]
12. Mixed infection with itraconazole-susceptible and-resistant strains of Aspergillus fumigatus: Diagnostic and therapeutic implications.
Ahmad S; Khan Z
J Infect Public Health; 2020 Apr; 13(4):664-666. PubMed ID: 32171723
[No Abstract] [Full Text] [Related]
13. [Severe Aspergillus keratomycosis treated with itraconazole per os].
Villard C; Lacroix C; Rabot MH; Rovira JC; Jacquemin JL
J Fr Ophtalmol; 1989; 12(4):323-5. PubMed ID: 2560784
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
Al-Nakeeb Z; Sudan A; Jeans AR; Gregson L; Goodwin J; Warn PA; Felton TW; Howard SJ; Hope WW
Antimicrob Agents Chemother; 2012 Aug; 56(8):4146-53. PubMed ID: 22615280
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
[TBL] [Abstract][Full Text] [Related]
16. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease.
Saulsbury FT
Clin Infect Dis; 2001 May; 32(10):E137-9. PubMed ID: 11317265
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole--perspectives for the management of invasive aspergillosis.
Groll AH
Mycoses; 2002; 45 Suppl 3():48-55. PubMed ID: 12690972
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
Kolwijck E; van der Hoeven H; de Sévaux RG; ten Oever J; Rijstenberg LL; van der Lee HA; Zoll J; Melchers WJ; Verweij PE
Am J Respir Crit Care Med; 2016 Apr; 193(8):927-9. PubMed ID: 27082535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
